Valuation: Cogstate Limited

Market Cap 628M 437M 388M 360M 327M 618M 41.45B 4.33B 1.7B 21.63B 1.64B 1.6B 68.96B P/E 2027 *
28.5x
P/E 2028 * 22.2x
Enterprise Value 563M 392M 348M 323M 294M 554M 37.19B 3.88B 1.52B 19.41B 1.47B 1.44B 61.86B EV / Sales 2027 *
5.19x
EV / Sales 2028 * 4.37x
Free-Float
56.43%
Yield 2027 *
1.36%
Yield 2028 * 1.66%
1 day+3.40%
1 week+5.80%
Current month+7.04%
1 month+14.42%
3 months+36.70%
6 months+52.08%
Current year+61.50%
1 week 3.24
Extreme 3.24
3.98
1 month 3.23
Extreme 3.23
3.98
Current year 2.01
Extreme 2.01
3.98
1 year 1.75
Extreme 1.75
3.98
3 years 0.8
Extreme 0.795
3.98
5 years 0.8
Extreme 0.795
3.98
10 years 0.16
Extreme 0.155
3.98
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 16/12/1999
Chief Executive Officer - 30/11/2005
Director of Finance/CFO - 31/01/2021
Director TitleAgeSince
Director/Board Member - 28/02/2011
Chairman 67 02/11/2009
Director/Board Member - 19/01/2017
Date Insider Type Main position Quantity % Market Cap. Importance
20/05/26 Buy

Director

3,600 0.0021%
20/05/26 Buy

Director

430 0.0003%
15/04/26
Myer & Myer Pty Ltd.
SellCompany 9,974,569 5.8334%
Change 5-day change 1-year change 3-year change Capi.($)
+3.40%+5.80%+40.38%+151.72% 420M
-6.60%-8.56%+42.79%+64.16% 68.98B
-4.09%-0.11%+2.31%+54.81% 53.15B
+0.03%+5.56%+10.18%+41.75% 50.83B
-1.53%+2.70%+29.72%+34.13% 44.61B
-1.34%+4.12%+16.05%+112.18% 42.53B
-5.97%-6.22%+258.21%+421.57% 40.57B
+6.53%+8.02%+15.74%+53.94% 30.95B
-0.90%-10.49%+31.48%-1.63% 25.44B
-2.76%-9.54%-16.53%-9.55% 22.66B
Average -1.32%+0.01%+43.03%+92.31% 38.01B
Weighted average by Cap. -2.42%-0.09%+44.73%+90.31%

Financials

2027 *2028 *
Net sales 108M 75.46M 67.08M 62.17M 56.56M 107M 7.16B 747M 293M 3.74B 283M 277M 11.91B 125M 86.79M 77.15M 71.5M 65.06M 123M 8.24B 859M 337M 4.3B 326M 319M 13.7B
Net income 22.07M 15.36M 13.65M 12.65M 11.51M 21.72M 1.46B 152M 59.62M 760M 57.63M 56.4M 2.42B 28.06M 19.52M 17.35M 16.08M 14.63M 27.61M 1.85B 193M 75.8M 967M 73.26M 71.7M 3.08B
Net Debt -64.61M -44.96M -39.96M -37.04M -33.7M -63.59M -4.27B -445M -175M -2.23B -169M -165M -7.1B -82.28M -57.25M -50.89M -47.17M -42.91M -80.98M -5.43B -567M -222M -2.84B -215M -210M -9.04B
Projected Income Statement - Annual - Cogstate Limited
Logo Cogstate Limited
Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.
Employees
160
Date Price Change Volume
16/10/26 A$3.650 +3.40% 196,076
15/10/26 A$3.530 -3.02% 704,749
14/10/26 A$3.640 -3.45% 445,260
13/10/26 A$3.770 -0.79% 1,041,057
12/10/26 A$3.800 +10.14% 1,011,050
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Cogstate Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.650AUD
Average target price
4.409AUD
Spread / Average Target
+20.80%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Cogstate Limited